Overuse of High Cumulative Doses of Oral Corticosteroids (OCS) in Severe Asthma Patients
Wednesday, May 15th at 12 pm (CST/SK)
OCS overuse is common and can substantially benefit from a multidisciplinary approach. Join us as Dr. Brianne Philipenko assesses the prevalence of asthma patients using high cumulative doses of OCS, and addresses which patients may benefit from asthma biologics.
Objectives for the Presentation:
- Introduce the concept of oral corticosteroid stewardship in asthma.
- Review the benefits and risks of oral corticosteroid use in the management of asthma.
- Discuss strategies for oral corticosteroid reduction in asthma management.
About Dr. Philipenko:
Dr. Philipenko is a Saskatoon respirologist and an Assistant Professor in the Division of Respirology at the University of Saskatchewan. She completed her medical training at the University of Saskatchewan followed by her respirology training at the University of Calgary. She acquired an additional fellowship in severe asthma at the University of Calgary. Severe asthma remains her primary clinical and research area of interest.
This webinar is proudly sponsored by GSK.